| The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection J Grebely, K Page, R Sacks‐Davis, MS van der Loeff, TM Rice, J Bruneau, ... Hepatology 59 (1), 109-120, 2014 | 505 | 2014 |
| Hepatitis C treatment for injection drug users: a review of the available evidence M Hellard, R Sacks-Davis, J Gold Clinical Infectious Diseases 49 (4), 561-573, 2009 | 314 | 2009 |
| A systematic examination of the use of online social networking sites for sexual health promotion J Gold, AE Pedrana, R Sacks-Davis, ME Hellard, S Chang, S Howard, ... BMC public health 11, 1-9, 2011 | 277 | 2011 |
| Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis J Stone, H Fraser, AG Lim, JG Walker, Z Ward, L MacGregor, A Trickey, ... The Lancet Infectious Diseases 18 (12), 1397-1409, 2018 | 217 | 2018 |
| The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs M Hellard, DA Rolls, R Sacks‐Davis, G Robins, P Pattison, P Higgs, ... Hepatology 60 (6), 1861-1870, 2014 | 164 | 2014 |
| Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection—the InC3 Study R Sacks-Davis, InC3 study group, J Grebely, InC3 Study Group, GJ Dore, ... The Journal of infectious diseases 212 (9), 1407-1419, 2015 | 116 | 2015 |
| The use of social networking platforms for sexual health promotion: identifying key strategies for successful user engagement HJ Veale, R Sacks-Davis, ERN Weaver, AE Pedrana, MA Stoové, ... BMC public health 15, 1-11, 2015 | 115 | 2015 |
| Young people’s comfort receiving sexual health information via social media and other sources MSC Lim, A Vella, R Sacks-Davis, ME Hellard International journal of STD & AIDS 25 (14), 1003-1008, 2014 | 107 | 2014 |
| Eradication of hepatitis C infection: the importance of targeting people who inject drugs M Hellard, JS Doyle, R Sacks‐Davis, AJ Thompson, E McBryde Hepatology 59 (2), 366-369, 2014 | 99 | 2014 |
| Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs R Sacks-Davis, G Daraganova, C Aitken, P Higgs, L Tracy, S Bowden, ... PloS one 7 (10), e47335, 2012 | 94 | 2012 |
| Hepatitis C transmission and treatment in contact networks of people who inject drugs DA Rolls, R Sacks-Davis, R Jenkinson, E McBryde, P Pattison, G Robins, ... PloS one 8 (11), e78286, 2013 | 80 | 2013 |
| The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design P Vickerman, J Grebely, GJ Dore, R Sacks-Davis, K Page, D L. Thomas, ... Journal of Infectious Diseases 205 (9), 1342-1350, 2012 | 78 | 2012 |
| Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia ME Hellard, R Jenkinson, P Higgs, MA Stoové, R Sacks‐Davis, J Gold, ... Medical journal of Australia 196 (10), 638-641, 2012 | 77 | 2012 |
| Randomised controlled trial of paper, online and SMS diaries for collecting sexual behaviour information from young people MSC Lim, R Sacks-Davis, CK Aitken, JS Hocking, ME Hellard Journal of Epidemiology & Community Health 64 (10), 885-889, 2010 | 77 | 2010 |
| Hepatitis C transmission and treatment as prevention–The role of the injecting network M Hellard, E McBryde, RS Davis, DA Rolls, P Higgs, C Aitken, ... International Journal of Drug Policy 26 (10), 958-962, 2015 | 72 | 2015 |
| High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study R Sacks-Davis, CK Aitken, P Higgs, T Spelman, AE Pedrana, S Bowden, ... PloS one 8 (11), e80216, 2013 | 71 | 2013 |
| Modelling hepatitis C transmission over a social network of injecting drug users DA Rolls, G Daraganova, R Sacks-Davis, M Hellard, R Jenkinson, ... Journal of theoretical biology 297, 73-87, 2012 | 69 | 2012 |
| Australia needs to increase testing to achieve hepatitis C elimination N Scott, R Sacks‐Davis, AJ Wade, M Stoove, A Pedrana, JS Doyle, ... Medical Journal of Australia 212 (8), 365-370, 2020 | 65 | 2020 |
| Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study EJ Aspinall, A Weir, R Sacks-Davis, T Spelman, J Grebely, P Higgs, ... International Journal of Drug Policy 25 (1), 179-182, 2014 | 65 | 2014 |
| Behavioural interventions for preventing hepatitis C infection in people who inject drugs: a global systematic review R Sacks-Davis, D Horyniak, J Grebely, M Hellard International Journal of Drug Policy 23 (3), 176-184, 2012 | 61 | 2012 |
Professor Joseph S. DoyleMonash University, The Alfred, Burnet Institute在 monash.edu 的电子邮件经过验证
